Bio-Techne (TECH) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bio-Techne Releases Second Quarter Fiscal 2017 Results
February 7, 2017 7:30 AM ESTMINNEAPOLIS, Feb. 7, 2017 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2016.
Second Quarter FY2017 Snapshot
Second quarter revenue increased by 9% to $131.8 million. GAAP fully diluted earnings per share (EPS) for the second quarter decreased 75% to $0.17 due to acquisition-related amortization, contingent consideration fair value adjustments, and other acquisition related costs. Delivered second quarter adjusted earnings per share (EPS) of $0.81, a decrease of 8% from the prior year, with foreign... More